How Noxopharm spent a pandemic-plagued 2020 leading the fight against cancer
Amid the tragedy of 2020’s global COVID-19 pandemic, it’s easy to forget the horrors inflicted on hundreds of
Amid the tragedy of 2020’s global COVID-19 pandemic, it’s easy to forget the horrors inflicted on hundreds of
Duchenne’s Muscular Dystrophy (DMD) is a devastating generic muscular wasting disorder with a 100% fatality rate . At
Antisense Therapeutics (ASX: ANP) is an Australian biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to
Prescient Therapeutics (ASX:PTX) are focused on developing novel, personalised therapies for a range of cancers through universal CAR-T
In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to
A main priority for many boards of large companies in recent years has been risk management, following a
Orthocell's (ASX: OCC) regenerative device, CelGro, is helping give mobility back to quadriplegic patients.
Orthocell Limited (ASX: OCC) is a world-leading regenerative medicine company providing innovative products to restore mobility, function and